Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 68,531
Sort by:

Vision Care Market - Global Outlook and Forecast 2019-2024

US$ 4,500.00

... other prominent companies operating in the global vision care market. Global Vision Care Market - Dynamics Over the last few years, ... in the global vision care market. Vision Care Products Market Segmentation This market research report includes a detailed segmentation of the market by products, distribution ...

March 2019 344 pages

Global Chlorhexidine Gluconate Solution Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... : This report studies the Chlorhexidine Gluconate Solution market status and outlook of global and major regions, from ... global and major regions, and splits the Chlorhexidine Gluconate Solution market by product type and applications/end industries. The worldwide market for Chlorhexidine Gluconate Solution ...

March 2019 135 pages

Global All Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the All Vaccine in global market, especially in North America, Europe ...

March 2019 123 pages

Global Bone Morphogenetic Protein (BMP) 2 Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... the top manufacturers of Bone Morphogenetic Protein (BMP) 2, with price, sales, revenue and global market share of Bone Morphogenetic Protein (BMP) 2 in 2017 and 2018. Chapter 3, the Bone Morphogenetic Protein (BMP) 2 competitive situation, sales ...

March 2019 103 pages

Global Intelligent Stethoscope (Smart Stethoscopes) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... the top manufacturers of Intelligent Stethoscope (Smart Stethoscopes), with price, sales, revenue and global market share of Intelligent Stethoscope (Smart Stethoscopes) in 2017 and 2018. Chapter 3, the Intelligent Stethoscope (Smart Stethoscopes) competitive situation, sales ...

March 2019 122 pages

Global Enzyme Replacement Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... been formed in the monopoly position in the industry. The global Enzyme Replacement Therapy market is valued at 7400 million USD in 2018 and is expected ... top players in global market, and splits the Enzyme Replacement Therapy market by product type and applications/end industries. Market Segment by Companies, ...

March 2019 119 pages

Global Electric Wheelchair (Powered Wheelchairs) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... the top manufacturers of Electric Wheelchair (Powered Wheelchairs), with price, sales, revenue and global market share of Electric Wheelchair (Powered Wheelchairs) in 2017 and 2018. Chapter 3, the Electric Wheelchair (Powered Wheelchairs) competitive situation, sales ...

March 2019 117 pages

Computational Biology Market Size, Share & Trends Analysis Report By Application (Cellular & Biological Simulation, Drug Discovery & Disease Modelling), By Service, By End Use, And Segment Forecasts, 2019 - 2026

US$ 5,950.00

The global computational biology market size is expected to reach USD 13.6 billion by 2026, according to a new report by Grand ... and pharmaco-genomics Some of the players operating in the computational biology market include Chemical Computing Group Inc.; Compugen Ltd.; Simulation Plus Inc.; Genedata ...

March 2019 105 pages

2019 Acinetobacter baumannii (Acinetobacter Infections) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Acinetobacter baumannii (Acinetobacter Infections) pipeline companies from advancing their products. Acinetobacter baumannii (Acinetobacter Infections) Report Description The H1-2019 pipeline review report on Acinetobacter baumannii (Acinetobacter Infections) is a comprehensive study ...

March 2019 150 pages

2019 African Trypanosomiasis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the African Trypanosomiasis pipeline companies from advancing their products. African Trypanosomiasis Report Description The H1-2019 pipeline review report on African Trypanosomiasis is a comprehensive study on drug candidates ...

March 2019 40 pages

2019 Anemia in Chronic Kidney Disease (Renal Anemia) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Anemia in Chronic Kidney Disease (Renal Anemia) pipeline companies from advancing their products. Anemia in Chronic Kidney Disease (Renal Anemia) Report Description The H1-2019 pipeline review report on Anemia in Chronic Kidney Disease (Renal Anemia ...

March 2019 86 pages

2019 Anthrax R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Anthrax pipeline companies from advancing their products. Anthrax Report Description The H1-2019 pipeline review report on Anthrax is a comprehensive study on drug candidates across different ...

March 2019 71 pages

2019 Aplastic Anemia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Aplastic Anemia pipeline companies from advancing their products. Aplastic Anemia Report Description The H1-2019 pipeline review report on Aplastic Anemia is a comprehensive study on drug candidates ...

March 2019 59 pages

2019 Aspergillosis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Aspergillosis pipeline companies from advancing their products. Aspergillosis Report Description The H1-2019 pipeline review report on Aspergillosis is a comprehensive study on drug candidates across different ...

March 2019 75 pages

2019 Bacillary Dysentery (Shigellosis) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Bacillary Dysentery (Shigellosis) pipeline companies from advancing their products. Bacillary Dysentery (Shigellosis) Report Description The H1-2019 pipeline review report on Bacillary Dysentery (Shigellosis ... and universities participating in the Bacillary Dysentery (Shigellosis) product pipeline are provided. ...

March 2019 40 pages

2019 Bacterial Vaginosis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Bacterial Vaginosis pipeline companies from advancing their products. Bacterial Vaginosis Report Description The H1-2019 pipeline review report on Bacterial Vaginosis is a comprehensive study on drug candidates ...

March 2019 50 pages

2019 Botulism R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Botulism pipeline companies from advancing their products. Botulism Report Description The H1-2019 pipeline review report on Botulism is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Burkholderia pseudomallei Infections (Melioidosis) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Burkholderia pseudomallei Infections (Melioidosis) pipeline companies from advancing their products. Burkholderia pseudomallei Infections (Melioidosis) Report Description The H1-2019 pipeline review report on Burkholderia pseudomallei Infections (Melioidosis) is a comprehensive study ...

March 2019 50 pages

2019 Candidiasis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Candidiasis pipeline companies from advancing their products. Candidiasis Report Description The H1-2019 pipeline review report on Candidiasis is a comprehensive study on drug candidates across different ...

March 2019 130 pages

2019 Chagas Disease (American Trypanosomiasis) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Chagas Disease (American Trypanosomiasis) pipeline companies from advancing their products. Chagas Disease (American Trypanosomiasis) Report Description The H1-2019 pipeline review report on Chagas Disease (American Trypanosomiasis) is a comprehensive study on drug ...

March 2019 65 pages

2019 Chikungunya Fever R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Chikungunya Fever pipeline companies from advancing their products. Chikungunya Fever Report Description The H1-2019 pipeline review report on Chikungunya Fever is a comprehensive study on drug candidates ...

March 2019 80 pages

2019 Chlamydia Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Chlamydia Infections pipeline companies from advancing their products. Chlamydia Infections Report Description The H1-2019 pipeline review report on Chlamydia Infections is a comprehensive study on drug candidates ...

March 2019 50 pages

2019 Cholera R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Cholera pipeline companies from advancing their products. Cholera Report Description The H1-2019 pipeline review report on Cholera is a comprehensive study on drug candidates across different ...

March 2019 45 pages

2019 Coccidioidomycosis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Coccidioidomycosis pipeline companies from advancing their products. Coccidioidomycosis Report Description The H1-2019 pipeline review report on Coccidioidomycosis is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Community Acquired Pneumonia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Community Acquired Pneumonia pipeline companies from advancing their products. Community Acquired Pneumonia Report Description The H1-2019 pipeline review report on Community Acquired Pneumonia ... providers and universities participating in the Community Acquired Pneumonia product pipeline are provided. Company ...

March 2019 70 pages

2019 Cryptococcosis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Cryptococcosis pipeline companies from advancing their products. Cryptococcosis Report Description The H1-2019 pipeline review report on Cryptococcosis is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Cryptosporidiosis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Cryptosporidiosis pipeline companies from advancing their products. Cryptosporidiosis Report Description The H1-2019 pipeline review report on Cryptosporidiosis is a comprehensive study on drug candidates across different ...

March 2019 35 pages

2019 Diphtheria R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Diphtheria pipeline companies from advancing their products. Diphtheria Report Description The H1-2019 pipeline review report on Diphtheria is a comprehensive study on drug candidates across different ...

March 2019 66 pages

2019 Elephantiasis (Lymphatic Filariasis) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Elephantiasis (Lymphatic Filariasis) pipeline companies from advancing their products. Elephantiasis (Lymphatic Filariasis) Report Description The H1-2019 pipeline review report on Elephantiasis (Lymphatic Filariasis ... universities participating in the Elephantiasis (Lymphatic Filariasis) product pipeline are ...

March 2019 30 pages

2019 Epstein–Barr Virus (EBV) Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Epstein–Barr Virus (EBV) Infections pipeline companies from advancing their products. Epstein–Barr Virus (EBV) Infections Report Description The H1-2019 pipeline review report on Epstein–Barr Virus (EBV) Infections is a comprehensive study on drug ...

March 2019 90 pages

2019 Fanconi Anemia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Fanconi Anemia pipeline companies from advancing their products. Fanconi Anemia Report Description The H1-2019 pipeline review report on Fanconi Anemia is a comprehensive study on drug candidates ...

March 2019 52 pages

2019 Genital Herpes R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Genital Herpes pipeline companies from advancing their products. Genital Herpes Report Description The H1-2019 pipeline review report on Genital Herpes is a comprehensive study on drug candidates ...

March 2019 67 pages

2019 Gonorrhea R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Gonorrhea pipeline companies from advancing their products. Gonorrhea Report Description The H1-2019 pipeline review report on Gonorrhea is a comprehensive study on drug candidates across different ...

March 2019 50 pages

2019 Haemophilus influenzae Type B Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Haemophilus influenzae Type B Infections pipeline companies from advancing their products. Haemophilus influenzae Type B Infections Report Description The H1-2019 pipeline review report on Haemophilus influenzae Type ... universities participating in the Haemophilus influenzae Type B Infections product pipeline ...

March 2019 60 pages

2019 Hand-Foot-Mouth Disease R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Hand-Foot-Mouth Disease pipeline companies from advancing their products. Hand-Foot-Mouth Disease Report Description The H1-2019 pipeline review report on Hand-Foot-Mouth Disease is a comprehensive study on drug candidates ...

March 2019 40 pages

2019 Hemophilia A R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Hemophilia A pipeline companies from advancing their products. Hemophilia A Report Description The H1-2019 pipeline review report on Hemophilia A is a comprehensive study on drug candidates ...

March 2019 120 pages

2019 Hemophilia B R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Hemophilia B pipeline companies from advancing their products. Hemophilia B Report Description The H1-2019 pipeline review report on Hemophilia B is a comprehensive study on drug candidates ...

March 2019 92 pages

2019 Hepatitis A R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Hepatitis A pipeline companies from advancing their products. Hepatitis A Report Description The H1-2019 pipeline review report on Hepatitis A is a comprehensive study on drug candidates ...

March 2019 30 pages

2019 Hepatitis D(HDV) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Hepatitis D(HDV) pipeline companies from advancing their products. Hepatitis D(HDV) Report Description The H1-2019 pipeline review report on Hepatitis D(HDV) is a comprehensive study on drug candidates ...

March 2019 50 pages

2019 Hepatitis E R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Hepatitis E pipeline companies from advancing their products. Hepatitis E Report Description The H1-2019 pipeline review report on Hepatitis E is a comprehensive study on drug candidates ...

March 2019 30 pages

2019 Herpes Labialis (Oral Herpes) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Herpes Labialis (Oral Herpes) pipeline companies from advancing their products. Herpes Labialis (Oral Herpes) Report Description The H1-2019 pipeline review report on Herpes Labialis (Oral Herpes) is a comprehensive study on drug ...

March 2019 50 pages

2019 Herpes Zoster (Shingles) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... the Herpes Zoster (Shingles) pipeline companies from advancing their products. Herpes Zoster (Shingles) Report Description The H1-2019 pipeline review report on Herpes Zoster (Shingles) is ... license providers and universities participating in the Herpes Zoster (Shingles) product pipeline are provided. Company ...

March 2019 45 pages

2019 Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections pipeline companies from advancing their products. Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Report Description The H1-2019 pipeline review report on Hospital Acquired Methicillin-Resistant Staphylococcus ...

March 2019 40 pages

2019 Hospital Acquired Pneumonia (HAP) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Hospital Acquired Pneumonia (HAP) pipeline companies from advancing their products. Hospital Acquired Pneumonia (HAP) Report Description The H1-2019 pipeline review report on Hospital Acquired Pneumonia (HAP) is a comprehensive study on drug ...

March 2019 75 pages

2019 Human herpesvirus 4(HHV-4) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... the Human herpesvirus 4(HHV-4) pipeline companies from advancing their products. Human herpesvirus 4(HHV-4) Report Description The H1-2019 pipeline review report on Human herpesvirus 4(HHV-4) ... providers and universities participating in the Human herpesvirus 4(HHV-4) product pipeline are provided. Company ...

March 2019 90 pages

2019 Human Parainfluenza Virus 3 Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Human Parainfluenza Virus 3 Infections pipeline companies from advancing their products. Human Parainfluenza Virus 3 Infections Report Description The H1-2019 pipeline review report on Human Parainfluenza Virus ... and universities participating in the Human Parainfluenza Virus 3 Infections product pipeline are ...

March 2019 35 pages

2019 Hypereosinophilic Syndrome R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Hypereosinophilic Syndrome pipeline companies from advancing their products. Hypereosinophilic Syndrome Report Description The H1-2019 pipeline review report on Hypereosinophilic Syndrome is a comprehensive study on drug candidates ...

March 2019 40 pages

2019 Idiopathic Thrombocytopenic Purpura (ITP) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Idiopathic Thrombocytopenic Purpura (ITP) pipeline companies from advancing their products. Idiopathic Thrombocytopenic Purpura (ITP) Report Description The H1-2019 pipeline review report on Idiopathic Thrombocytopenic Purpura (ITP) is a comprehensive study on drug ...

March 2019 82 pages

2019 Immune Thrombocytopenic Purpura R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Immune Thrombocytopenic Purpura pipeline companies from advancing their products. Immune Thrombocytopenic Purpura Report Description The H1-2019 pipeline review report on Immune Thrombocytopenic Purpura ... and universities participating in the Immune Thrombocytopenic Purpura product pipeline are provided. Company ...

March 2019 82 pages

2019 Impetigo R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Impetigo pipeline companies from advancing their products. Impetigo Report Description The H1-2019 pipeline review report on Impetigo is a comprehensive study on drug candidates across different ...

March 2019 30 pages

Filters

Search

Categories

186
1,003
31
222
180
154
139
126
63,609
1,041
751
929
160

Publishers

179
1
239
347
389
103
826
148
348
3
202
3
6
1,620
487
76
123
208
111
25
1,049
378
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,806
60
1,696
8
7,373
2,207
4,664
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
354
8
3
18
58
906
6
89
12
24
15
1,285
227
128
386
3
74
10
119
230
46
474
26
133
4

Regions

89
58
45
41
41
35
31
30
30
29
28
28
28
26
21
18
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
795
495
2
2
2
117
195
102
53
23
704
26
134
526
174
627
63,501

Price

Date

Pages

Offers

1
280
1
1